PAS
BNGO icon

Point72 Asia (Singapore)’s Bionano Genomics BNGO Stock Holding History

Point72 Asia (Singapore)’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-242
Closed -$16.1K – 1078
2024
Q1 		$16.1K Buy
+242
New +$18.1K ﹤0.01% 976

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Point72 Asia (Singapore)'s BNGO Position: Q2 2024 in Review

Point72 Asia (Singapore) sold out of Bionano Genomics (BNGO) in Q2 2024, closing a stake of 242 shares — an estimated $16.1K sold.

Point72 Asia (Singapore) first reported a position in BNGO in Q1 2024 and held it in 1 quarter. The position peaked at $16.1K in Q1 2024. 53 funds tracked by Wall St. Rank hold BNGO as of Q2 2024.

  • Point72 Asia (Singapore) reported no remaining Bionano Genomics position as of Q2 2024 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 242 Bionano Genomics shares in Q2 2024, an estimated $16.1K.
  • Point72 Asia (Singapore) first reported a position in Bionano Genomics in Q1 2024 and held it in 1 quarter.
  • Point72 Asia (Singapore)'s Bionano Genomics position peaked at $16.1K in Q1 2024.
  • 53 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2024.

Based on Point72 Asia (Singapore)'s 13F filing for Q2 2024, filed 14 Aug 2024.